Lakeland, FL -- (SBWIRE) -- 08/19/2013 -- Penny Stock Divas is composed of a team of market professionals consisting of research analysts, technical chartists and traders. With over 50 years of combined experience, we work diligently to provide you with accurate information on our best penny stoc k picks. Here Penny Stock Divas brings a special report on: China Logistics Group Inc (OTCMKTS:CHLO), BANCO DO BRASIL SA (OTCMKTS:BDORY), Cellceutix Corp (OTCBB:CTIX), FUSE SCIENCE, INC (OTCMKTS:DROP)
China Logistics Group Inc (OTCMKTS:CHLO) increased 67.06% and closed at $0.0142 on a traded volume of 6.20 million shares, in comparison to 2.34 million shares of average trading volume. So far this year, the stock is up over 373.33%.
The company has a total market capitalization of $589,416.00 and its total outstanding shares are 41.51 million. China Logistics Group, Inc., sells cargo space and arranges international transportation through land, maritime and air routes primarily for clients seeking to export goods from China. The Company’s subsidiary, Shandong Jiajia International Freight and Forwarding Co., Ltd. (Shandong Jiajia), acts as an agent for international freight and shipping companies.
For How Long CHLO will Fight for Profitability? Read This Trend Analysis report
BANCO DO BRASIL SA (OTCMKTS:BDORY) plunged -2.77% and closed at $9.83 on a traded volume of 58,998.00 shares, whereas its average trading volume is 104,005.00 shares. In the last three months, the stock is down -23.5%. The Intra-day range for the stock is $9.78 and $10.04. Banco do Brasil S.A. provides various banking services in Brazil and internationally. Its Banking segment offers products and services, such as deposits, loans, and services to retail, wholesale, and government markets, as well as to micro-entrepreneurs and the informal sector.
Has BDORY Found The Bottom And Ready To Gain Momentum? Find Out Here
Cellceutix Corp (OTCBB:CTIX) jumped up 1.02% and closed at $1.98. So far in three months, the stock is down -1.49%. The 52-week range for the stock is $0.60 and $2.47 and during the previous trading session the stock touched its highest price at $1.99. Its introductory price for the day was $1.95, with the overall traded volume of 147,830.00 shares. Cellceutix Corporation is an early-stage developmental biopharmaceutical company. The Company has acquired exclusive rights to eight different pharmaceutical compound candidates that are designed for treatment of diseases which exist, or may exist in the future.
Will CTIX Continue To Move Higher? Find Out Here
FUSE SCIENCE, INC (OTCMKTS:DROP) after opening its shares at the price of $0.08, dropped -1.23% to close at $0.0800 for the day. The stock moved on a traded volume of 1.64 million shares, in comparison to 820,357.00 shares of average trading volume.
The 52-week range for the stock is $0.07 and $0.28 and during the previous trading session the stock touched its highest price at $0.08. Its introductory price for the day was $0.08. Fuse Science, Inc., a consumer products company, develops alternative delivery systems with applications in the sports nutrition and medical fields. Its delivery systems include sublingual and transdermal delivery technologies that enable energy, medicines, vitamins, and minerals to bypass the gastrointestinal tract and enter the blood stream directly.
Will DROP Get Buyers Even After The Recent Rally? Find Out Here
About Penny Stock Divas
PSD is composed of a team of market professionals consisting of research analysts, technical chartists and traders. With over 50 years of combined experience, we work diligently to provide you with accurate information on our penny stock picks. We use social media tools such as Twitter and Facebook, enabling you to receive time sensitive information in a real-time manner. When you sign up for our FREE penny stock newsletter, you will receive our latest hot penny stock alerts! We have new investment ideas for penny stocks with research and commentary in the penny stock market.
PSD is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and the company website, but this should not be construed as a recommendation to buy or sell.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)